 |
Articles: Pharmacology/Therapy |
Prior Articles
Rectal Filling at Planning Does Not Predict Stability of the Prostate Gland during a Course of Radical Radiotherapy if Patients with Large Rectal Filling are Re-imaged
Clinical Oncology, 11/12/09
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours
European Journal of Cancer, 11/12/09 Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation, 11/12/09 The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study
Breast Cancer Research and Treatment, 11/12/09 Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides
Expert Review of Anticancer Therapy, 11/12/09
Revew Article
Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma
Expert Review of Anticancer Therapy, 11/12/09
Free full text
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
Journal of Clinical Oncology, 11/12/09 Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Journal of Clinical Oncology, 11/12/09 Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: An open-label, randomised controlled trial
The Lancet Oncology - Online First, 11/11/09 Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/11/09 Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma
Cancer, 11/11/09 Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
Journal of Clinical Oncology, 11/11/09 A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
Annals of Oncology, 11/11/09 Pegylated Liposomal Doxorubicin and Carboplatin in Late-relapsing Ovarian Cancer: A GINECO Group Phase II Trial
Anticancer Research, 11/11/09 Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma
Anticancer Research, 11/11/09 Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)
British Journal of Haematology, 11/11/09 Cancer Nanotargeted Radiopharmaceuticals for Tumor Imaging and Therapy
Anticancer Research, 11/11/09 High-dose Octreotide Acetate for Management of Gastroenteropancreatic Neuroendocrine Tumors
Anticancer Research, 11/11/09 Single-institution Outcome of High-dose Interleukin-2 (HD IL-2) Therapy for Metastatic Melanoma and Analysis of Favorable Response in Brain Metastases
Anticancer Research, 11/11/09 Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: Effects of rituximab
Annals of Oncology, 11/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
